Concepedia

Maria Pinkerneil

MP

Statistics

Publications

8

Citations

456

H-Index

8

Active since

2016

Affiliations

Heinrich Heine University Düsseldorf(Current)

Maria Pinkerneil is an author at Heinrich Heine University Düsseldorf specializing in urothelial carcinoma, molecular oncology, and oncology.

Publications per year

2016–2018

8

Publications

8

Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine

Makoto Isono, Michèle J. Hoffmann, Maria Pinkerneil et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 81 citations · Full text

, , +17

Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines

Alexander Sebastian Hölscher, Wolfgang A. Schulz, Maria Pinkerneil et al. · Clinical Epigenetics · 2018 · 80 citations · Full text

, , +15

Effects of novel HDAC inhibitors on urothelial carcinoma cells

Aline Kaletsch, Maria Pinkerneil, Michèle J. Hoffmann et al. · Clinical Epigenetics · 2018 · 76 citations · Full text

, , +10

Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms

Maria Pinkerneil, Michèle J. Hoffmann, René Deenen et al. · Molecular Cancer Therapeutics · 2016 · 63 citations

, , +16

Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines

Maria Pinkerneil, Michèle J. Hoffmann, Hella Kohlhof et al. · Targeted Oncology · 2016 · 57 citations · Full text

, , +15

1–5 of 8